What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Enzyme
Internal medicine, Endocrinology, Cholesterol, Lipoprotein and Apolipoprotein B are his primary areas of study.
His Internal medicine study incorporates themes from Immunology and Cardiology.
Daniel J. Rader has included themes like Apolipoprotein E and In vivo in his Endocrinology study.
His Cholesterol study deals with the bigger picture of Biochemistry.
The study incorporates disciplines such as Familial hypercholesterolemia, Microsomal triglyceride transfer protein, Catabolism, LDL receptor and Molecular biology in addition to Apolipoprotein B.
His work deals with themes such as Genome-wide association study and Vascular disease, which intersect with Coronary artery disease.
His most cited work include:
- Intensive versus moderate lipid lowering with statins after acute coronary syndromes. (3936 citations)
- Biological, clinical and population relevance of 95 loci for blood lipids (2804 citations)
- Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. (1823 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Internal medicine, Endocrinology, Cholesterol, Lipoprotein and Apolipoprotein B.
Daniel J. Rader regularly ties together related areas like Cardiology in his Internal medicine studies.
His study in Endocrinology is interdisciplinary in nature, drawing from both Apolipoprotein E and In vivo.
His research integrates issues of Efflux and Pharmacology in his study of Cholesterol.
His studies link Receptor with Lipoprotein.
His research investigates the connection with Coronary artery disease and areas like Genome-wide association study which intersect with concerns in Bioinformatics.
He most often published in these fields:
- Internal medicine (57.41%)
- Endocrinology (40.29%)
- Cholesterol (27.85%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (57.41%)
- Cardiology (10.65%)
- Genome-wide association study (9.91%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Cardiology, Genome-wide association study, Coronary artery disease and Endocrinology.
His research in Internal medicine intersects with topics in Gastroenterology and Mendelian randomization.
His Genome-wide association study research includes elements of Computational biology, Genetic variation and Genetic association.
His Endocrinology research focuses on Diabetes mellitus in particular.
Cholesterol is a component of his Lipoprotein, High-density lipoprotein and Apolipoprotein B studies.
His work carried out in the field of Lipoprotein brings together such families of science as Receptor and Cell biology.
Between 2017 and 2021, his most popular works were:
- A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease (263 citations)
- Multi-Ethnic Genome-wide Association Study for Atrial Fibrillation (229 citations)
- Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program. (203 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Enzyme
His primary areas of investigation include Internal medicine, Genome-wide association study, Endocrinology, Bioinformatics and Apolipoprotein B.
His Internal medicine study frequently involves adjacent topics like Cardiology.
His Endocrinology study combines topics in areas such as Glycosylation and Developmental disorder.
His Bioinformatics research includes themes of LDL receptor, Disease, Cholesterol, Thrombosis and Dilated cardiomyopathy.
His research in the fields of High-density lipoprotein overlaps with other disciplines such as Epiphenomenon.
Daniel J. Rader combines subjects such as Coronary heart disease, Secretion, PCSK9, Efflux and Lipoprotein with his study of Apolipoprotein B.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
